Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
06/2014
06/19/2014US20140170064 Methods and compositions for radiohalogen protein labeling
06/18/2014EP2743270A1 Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs
06/18/2014CN103864892A Peptide tyrosinase inhibitors and uses thereof
06/18/2014CN103864891A Chinese chive seed antioxidative tripeptide, and preparation and application thereof
06/18/2014CN103864890A Imidazolisopropylacetyltheaninecarbobenzoxypyridoindole, and preparation method, nanostructure and application thereof
06/18/2014CN103864889A Epoxy ketone compound, preparation method thereof and preparation method of kyprolis
06/18/2014CN103864885A Application of 1-hydroxy-1,2,3-phentriazine-4(3H)-one in polypeptide synthesis
06/18/2014CN102977186B Glycine-L-cysteine-homotaurine tripeptide and application thereof
06/18/2014CN102875651B Anti-tumor target-activated polypeptide doxorubicin and preparation method and application thereof
06/18/2014CN102807602B Peptide and composition thereof for improving liver dysfunction
06/18/2014CN102675415B Method for preparing bortezomib
06/18/2014CN102413842B Prodrugs
06/18/2014CN102316886B Skin aging-inhibiting peptide
06/17/2014US8754190 Controlled release from macromolecular conjugates
06/17/2014US8754049 Organic compound for the regulation of vectorial ion channels
06/12/2014WO2014089189A2 Internet protocol television streaming method, system, and apparatus
06/12/2014US20140163231 Hepatitis C Virus Inhibitors
06/12/2014US20140163203 Process for preparing eptifibatide
06/12/2014US20140162955 Antagonizing Heparin With Salicylamide Compounds And Histamine Blocking Agents
06/12/2014US20140161777 Methods and compositions for treating brain diseases
06/11/2014EP2740734A1 Hcv protease inhibitors
06/11/2014CN102702310B Marine peptides compounds and application of marine peptides compounds to preparation of angiogenesis medicines
06/10/2014US8748373 Hepatitis B virus compositions and methods of use
06/10/2014US8748371 Nuclear targeting sequences
06/10/2014US8748367 Use of antisecretory factor
06/05/2014WO2014085637A1 New lantibiotic derivatives and a process for their preparation
06/05/2014WO2014083578A1 A process for the preparation of solomonamide analogues
06/05/2014US20140155576 F11 receptor (f11r) antagonists as therapeutic agents
06/05/2014US20140154272 Compound and method for modulating opioid receptor activity
06/05/2014US20140154192 Glutathione analogs and uses thereof
06/04/2014EP2736920A1 Notch pathway signaling inhibitor compound
06/04/2014EP2736523A1 Modulators of protease activated receptors
06/04/2014CN103842371A Silk-based bioactive oligopeptide compositions and manufacturing process therefor
06/04/2014CN103833827A Amide compounds, medicine compositions, preparation method and application thereof
06/04/2014CN103833826A Method for preparing niacin-glutathione-trivalent chromium ion chelate
06/04/2014CN103833760A Piperazidines derivate
06/04/2014CN102924567B Peptide compound and preparation method and use of peptide compound
06/04/2014CN102863510B N (2)-L-alanyl-L-glutamine synthetic method
06/03/2014US8742067 Anti-tumor drug, medicament, composition, and use thereof
06/03/2014US8741850 Compounds modulators of VEGF activity and uses thereof
06/03/2014US8741838 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
06/03/2014US8741288 Protein markers for detecting liver cancer and method for identifying the markers thereof
05/2014
05/30/2014WO2014080376A2 Pro-pigmenting peptides
05/30/2014WO2014079583A1 Chondramide derivatives
05/29/2014US20140148574 Synthesis of an intermediate of an antiviral compound
05/29/2014US20140148382 Peptide compositions and methods for treating patients
05/29/2014US20140147412 Spiro compounds as hepatitis c virus inhibitors
05/28/2014EP2735569A1 Method for producing lanthionine derivative
05/28/2014CN103819538A 钙结合肽 Calcium binding peptide
05/28/2014CN103819537A 抗病毒化合物 Antiviral compounds
05/28/2014CN103819459A 抗病毒化合物 Antiviral compounds
05/28/2014CN102388023B 有机化合物和它们的用途 Organic compounds and their use
05/28/2014CN101472944B 用于诱导细胞外基质蛋白合成的肽片段 For inducing synthesis of extracellular matrix protein peptide fragments
05/27/2014US8735360 Treatments for gastrointestinal disorders
05/27/2014US8735341 Non-viral delivery of compounds to mitochondria
05/22/2014WO2014076422A1 Substituted anionic compounds consisting of a backbone consisting of a discrete number of saccharide units
05/22/2014WO2014075137A1 Peptides incorporating amino-substituted lactams for treatment of retinopathy
05/22/2014WO2014011624A3 Stabilized multi-functional antioxidant compounds and methods of use
05/22/2014US20140142050 Advantageous salts of mu-opiate receptor peptides
05/22/2014US20140142029 Macrocyclic broad spectrum antibiotics
05/22/2014US20140140925 Folate-targeted diagnostics and treatment
05/21/2014EP2733150A1 Aromatic-cationic peptides and uses of same
05/21/2014EP2733149A1 Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
05/21/2014EP2733147A1 Boronate ester compounds and pharmaceutical compositions thereof
05/21/2014EP2731959A1 Enkephalin analogues
05/21/2014CN103804469A 卡非佐米中间体的制备方法 Preparation of non-bortezomib intermediates card
05/21/2014CN103044523B 地塞米松-rgd多肽缀合物，其制备方法及应用 Dexamethasone -rgd polypeptide conjugates, their preparation and application
05/21/2014CN103012554B 氢化可的松-rgd多肽缀合物，其制备方法及应用 Hydrocortisone -rgd polypeptide conjugates, their preparation and application
05/21/2014CN102264757B 制备比伐卢定的方法 Bivalirudin is prepared
05/21/2014CN102260189B 一种制备n(2)-l-丙氨酰-l-谷氨酰胺的关键中间体n(2)-d-2-氯丙酰-l-谷氨酰胺的方法 A method for preparing n (2) -l- alanyl glutamine -l- key intermediate n (2) -d-2- chloropropionyl -l- method glutamine
05/20/2014US8729228 Method of producing a modified (poly) peptide
05/20/2014US8729014 Specific HCV NS3 protease inhibitors
05/20/2014US8728496 Functionalized RGD peptidomimetics and their manufacture, and implant having a coating containing such functionalized RGD peptidomimetics
05/20/2014CA2471192C Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
05/15/2014WO2014075079A1 Peptidic structures incorporating an amino acid metal complex and applications in magnetic resonance imaging
05/15/2014WO2014074658A1 Macrocyclic compounds for inhibition of inhibitors of apoptosis
05/15/2014WO2014072897A1 Anti-notch3 antibodies and antibody-drug conjugates
05/15/2014WO2013028615A3 Novel cyclosporin derivatives for the treatment and prevention of viral infections
05/14/2014EP2730581A1 Boronate ester compounds and pharmaceutical compositions thereof
05/14/2014EP2730580A1 Boronate ester compounds and pharmaceutical compositions thereof
05/14/2014EP2730579A1 Boronate ester compounds and pharmaceutical compositions thereof
05/14/2014EP2729485A1 Anti - amyloidogenic, alpha-helix breaking ultra-small peptide therapeutics
05/14/2014EP2729484A1 Cyclic tripeptide mimetics as plasmin inhibitors
05/14/2014EP2729483A1 Glutathione analogs and uses thereof
05/14/2014EP2729443A1 Benzylamine derivatives as inhibitors of plasma kallikrein
05/14/2014CN103797024A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
05/14/2014CN103788175A 一种谷胱甘肽的制备方法 Method for preparing glutathione
05/14/2014CN102731628B 一种制备罗莫肽的方法 A process for preparing a peptide Romo
05/14/2014CN102159285B 作为hcv ns3蛋白酶抑制剂的大环喹喔啉化合物 As hcv ns3 protease inhibitors macrocyclic compounds quinoxaline
05/13/2014US8722852 Cosmetic composition for stimulating the synthesis of proteins of the basement membrane
05/13/2014US8722850 Self-assembling peptides and their use in the formation of hydrogels
05/13/2014US8722629 Auristatin derivatives and use thereof
05/13/2014US8722627 Proteasome-activating lightening peptidic hydrolyzates and compositions containing them
05/13/2014CA2617095C Macrocylic inhibitors of hepatitis c virus
05/08/2014WO2014071032A1 Hepatitis c virus inhibitors
05/08/2014WO2014071007A1 Hepatitis c virus inhibitors
05/08/2014WO2014070974A1 Hepatitis c virus inhibitors
05/08/2014WO2014070964A1 Hepatitis c virus inhibitors
05/08/2014WO2014070757A1 Compositions and methods for enhancing plant growth
05/08/2014WO2014069523A1 Carnosadine lactam derivative having antibacterial activity
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 307